1. Home
  2. NBIX vs EQX Comparison

NBIX vs EQX Comparison

Compare NBIX & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$130.61

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Equinox Gold Corp.

EQX

Equinox Gold Corp.

HOLD

Current Price

$15.63

Market Cap

12.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
EQX
Founded
1992
2007
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
12.3B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
NBIX
EQX
Price
$130.61
$15.63
Analyst Decision
Strong Buy
Buy
Analyst Count
22
1
Target Price
$180.82
$17.00
AVG Volume (30 Days)
901.1K
9.7M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
0.10%
EPS Growth
41.95
N/A
EPS
4.67
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$22.85
$95.14
Revenue Next Year
$10.36
$11.73
P/E Ratio
$27.09
$137.41
Revenue Growth
977.51
N/A
52 Week Low
$97.30
$5.64
52 Week High
$160.18
$18.96

Technical Indicators

Market Signals
Indicator
NBIX
EQX
Relative Strength Index (RSI) 50.14 57.45
Support Level $124.29 $13.54
Resistance Level $136.23 $17.40
Average True Range (ATR) 4.29 0.69
MACD -0.08 0.29
Stochastic Oscillator 59.64 95.55

Price Performance

Historical Comparison
NBIX
EQX

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About EQX Equinox Gold Corp.

Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.

Share on Social Networks: